IGC Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	21	21	24	17	44	69
Market Cap Growth	-10.23%	-14.22%	47.68%	-61.97%	-36.97%	294.62%
Enterprise Value	20	21	24	12	33	68
Last Close Price	0.22	0.26	0.37	0.28	0.88	1.39
PS Ratio	22.45	17.87	19.65	19.78	122.03	90.43
PB Ratio	3.07	3.59	3.61	1.21	2.03	2.48
P/TBV Ratio	7.73	5.07	4.63	1.31	2.11	2.51
EV/Sales Ratio	21.65	17.71	18.91	14.82	93.57	88.35
Debt / Equity Ratio	0.02	0.04	0.05	0.03	0.03	0.03
Net Debt / Equity Ratio	-0.12	-0.03	-0.12	-0.19	-0.41	-0.41
Net Debt / EBITDA Ratio	0.13	0.02	0.09	0.26	0.71	1.64
Net Debt / FCF Ratio	0.18	0.03	0.16	0.39	1.28	1.11
Asset Turnover	0.11	0.14	0.10	0.04	0.01	0.03
Inventory Turnover	0.55	0.45	0.29	0.15	0.04	0.14
Quick Ratio	0.79	0.21	0.55	1.83	4.53	6.27
Current Ratio	1.32	1.28	1.58	3.41	6.19	9.93
Return on Equity (ROE)	-83.34%	-104.33%	-116.95%	-59.30%	-52.97%	-29.70%
Return on Assets (ROA)	-50.31%	-49.91%	-45.23%	-32.86%	-29.10%	-16.81%
Return on Capital Employed (ROCE)	-98.40%	-114.70%	-129.60%	-75.70%	-59.80%	-26.00%
Earnings Yield	-25.96%	-31.36%	-49.20%	-63.85%	-31.00%	-10.85%
FCF Yield	-22.66%	-21.61%	-20.20%	-40.83%	-15.89%	-15.11%
Buyback Yield / Dilution	-19.49%	-30.04%	-11.91%	-5.17%	-19.13%	-6.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.